Condensed Consolidated Statements of Operations (USD $) In Thousands, except Share data	3 Months Ended		6 Months Ended
	Jun. 30, 2011	Jun. 30, 2010	Jun. 30, 2011	Jun. 30, 2010
Revenues	$ 767	$ 221	$ 1,136	$ 576
Cost of revenues	237	255	475	594
Gross profit	530	(34)	661	(18)
Sales and marketing expenses	305	262	621	581
General and administrative expenses	827	1,041	1,621	2,136
Research and development costs	429	418	830	701
Operating loss	(1,031)	(1,755)	(2,411)	(3,436)
Loss on extinguishment of debt	0	(363)	0	(6,006)
Gain (Loss) from change in fair value of hybrid financial instruments	(15,899)	1,180	(13,428)	19,552
Gain (loss) from change in fair value of derivative liability - warrants	(87)	4,305	1,695	10,856
Gain (Loss) from change in fair value of derivative liability - Series C and D preferred stock and debentures	(37,941)	6,645	(31,270)	46,824
Interest expense related to convertible debt	(904)	(510)	(1,657)	(956)
Net Income (loss)	(55,862)	9,502	(47,071)	66,834
Dividends on convertible preferred stock			0	(2,500)
Net income (loss) attributable to common shareholders	(55,862)	9,502	(47,071)	64,334
Comprehensive income (loss):
Net Income (loss)	(55,862)	9,502	(47,071)	66,834
Other comprehensive loss - foreign currency translation adjustment	(4)	(26)	(13)	(50)
Comprehensive income (loss)	$ (55,866)	$ 9,476	$ (47,084)	$ 66,784
Net income (loss) per share, basic and diluted:
Basic (in dollars per share)	$ (0.41)	$ 0.42	$ (1.02)	$ 2.84
Fully diluted (in dollars per share)	$ (0.41)	$ (0.01)	$ (1.02)	$ (0.02)
Weighted average number of common shares:
Basic (in shares)	137,692,460	22,675,678	46,114,822	22,675,678
Fully diluted (in shares)	137,692,460	302,104,430	46,114,822	299,092,068